Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Completed · Phase 2

Conditions studied: Glaucoma and Ocular Hypertension

In brief

This is a multiple cohort study that will evaluate the safety and efficacy of ENV515 travoprost XR in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT02371746

Run by

Envisia Therapeutics

People needed

41

Starts

2015-01-01

Expected to finish

2019-02-13

Last updated by the study team

2019-10-17

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of either ocular hypertension or open angle glaucoma in both eyes.
• Are currently treated with topical PGA for ocular hypertension in both eyes.
• Patients who in the opinion of the Investigator: have an IOP in both eyes that is considered to be adequately controlled, can be safely withdrawn from IOP medications in both eyes during the washout period, and who are not considered to be at significant risk for disease progression throughout the trial.

You may not qualify if…

• Eye surgery (including cataract surgery) within the past 3 months.
• History of glaucoma related surgery.

Where it is running

• Study site — Chandler, Arizona, United States
• Study site — Garden Grove, California, United States
• Study site — Inglewood, California, United States
• Study site — Redding, California, United States
• Study site — Morrow, Georgia, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Chesterfield, Missouri, United States
• Study site — Kansas City, Missouri, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Sioux Falls, South Dakota, United States
• Study site — Austin, Texas, United States
• Study site — Houston, Texas, United States
• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.